Precision Oncology Beyond Genomics: The Future Is Here—It Is Just Not Evenly Distributed
Cancer is a multifactorial disease with increasing incidence. There are more than 100 different cancer types, defined by location, cell of origin, and genomic alterations that influence oncogenesis and therapeutic response. This heterogeneity between tumors of different patients and also the heterog...
Main Authors: | Ulrike Pfohl, Alina Pflaume, Manuela Regenbrecht, Sabine Finkler, Quirin Graf Adelmann, Christoph Reinhard, Christian R. A. Regenbrecht, Lena Wedeken |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/4/928 |
Similar Items
-
Functional Precision Medicine Successfully Guides Therapeutic Regimen of ‘Cancer of Unknown Primary’ Later Classified as Triple-Negative Breast Cancer: A Case Report
by: Larissa Ruhe, et al.
Published: (2024-03-01) -
Implication of Intra-Tumor Heterogeneity on Colorectal Cancer Response to MEK Inhibition
by: Christian Regenbrecht
Published: (2023-03-01) -
A RAS-Independent Biomarker Panel to Reliably Predict Response to MEK Inhibition in Colorectal Cancer
by: Ulrike Pfohl, et al.
Published: (2022-07-01) -
Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models
by: Siyer Roohani, et al.
Published: (2023-06-01) -
Infertile human endometrial organoid apical protein secretions are dysregulated and impair trophoblast progenitor cell adhesion
by: Wei Zhou, et al.
Published: (2022-12-01)